PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,033 | -14.8% | 12,250 | +17.6% | 0.00% | – |
| Q2 2023 | $149,157 | +33.6% | 10,416 | +3.3% | 0.00% | – |
| Q3 2022 | $111,686 | +26.2% | 10,080 | -3.9% | 0.00% | – |
| Q2 2022 | $88,485 | -60.7% | 10,484 | -8.4% | 0.00% | – |
| Q4 2021 | $225,000 | -37.3% | 11,443 | +2.3% | 0.00% | – |
| Q3 2021 | $359,000 | -10.7% | 11,190 | -5.9% | 0.00% | – |
| Q2 2021 | $402,000 | +50.0% | 11,889 | +66.9% | 0.00% | – |
| Q1 2021 | $268,000 | +17.5% | 7,124 | +3.9% | 0.00% | – |
| Q4 2020 | $228,000 | -7.7% | 6,857 | +1.7% | 0.00% | – |
| Q3 2020 | $247,000 | +8.8% | 6,744 | 0.0% | 0.00% | – |
| Q2 2020 | $227,000 | – | 6,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
| Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
| Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
| Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
| Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
| Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
| StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
| MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
| NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |